AR032520A1 - COMPOUNDS - Google Patents

COMPOUNDS

Info

Publication number
AR032520A1
AR032520A1 ARP020100274A ARP020100274A AR032520A1 AR 032520 A1 AR032520 A1 AR 032520A1 AR P020100274 A ARP020100274 A AR P020100274A AR P020100274 A ARP020100274 A AR P020100274A AR 032520 A1 AR032520 A1 AR 032520A1
Authority
AR
Argentina
Prior art keywords
compounds
relates
present
methylbenzylamino
imidazo
Prior art date
Application number
ARP020100274A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR032520A1 publication Critical patent/AR032520A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invencion se refiere a nuevas formas cristalinas de la sal de clorhidrato de 2,3-dimetil-8(2etil-6metibencilamino)-imidazo[1,2-a]piridina-6carboxamida. Además, la presente invencion se refiere también al uso de dichos compuestos parta el tratamiento de desordenes gastrointestinales, a las composiciones farmacéuticas que los contienen y a los procedimientos para obtenerlos.The present invention relates to novel crystalline forms of the 2,3-dimethyl-8 (2-ethyl-6-methylbenzylamino) -imidazo [1,2-a] pyridine-6-carboxamide hydrochloride salt. In addition, the present invention also relates to the use of said compounds for the treatment of gastrointestinal disorders, the pharmaceutical compositions containing them and the methods for obtaining them.

ARP020100274A 2001-02-01 2002-01-25 COMPOUNDS AR032520A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100295A SE0100295D0 (en) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
AR032520A1 true AR032520A1 (en) 2003-11-12

Family

ID=20282797

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100274A AR032520A1 (en) 2001-02-01 2002-01-25 COMPOUNDS

Country Status (3)

Country Link
AR (1) AR032520A1 (en)
SE (1) SE0100295D0 (en)
WO (1) WO2002060442A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326718B2 (en) 2002-11-19 2008-02-05 Altana Pharma Ag 8-Substituted imidazopyridines
WO2005041961A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (en) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
SE0100295D0 (en) 2001-02-01
WO2002060442A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
ECSP088413A (en) PREPARATION AND USE OF TETRAHYDROPIRROLO DERIVATIVES [3,2-C] PIRIDIN-4-ONA FOR THE TREATMENT OF OBESITY, PSYCHIATRIC AND NEUROLOGICAL DISORDERS
UY27740A1 (en) NEW COMPOUNDS
UY28376A1 (en) THERAPEUTIC AGENTS
AR052447A1 (en) 1- (2-METIPROPIL) ETANSULFONATE -1H-IMIDAZO [4,5-C] [1,5] NAFTIRIDIN-4- AMINA AND 1- (2- METIPROPIL) -1H-IMIDAZO [4,5-C ] [1,5] NAFTIRIDIN-4-AMINA
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034744A (en) N-REPLACED N-REPLACED NMDA / NR2B ANTAGONISTS
CR6726A (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
ECSP088404A (en) NEW IMIDAZO DERIVATIVES [4,5-B] PIRIDINE AS INHIBITORS OF THE GLUCÓGENO SINTASA QUINASA 3, FOR USE IN THE TREATMENT OF DEMENTIA AND NEURODEGENERATIVE DISORDERS
BG111017A (en) New crystalline and amorphous forms of the triazolo(4,5-d)pyrimidine compound
DOP2002000392A (en) SALES TARTRATE OF 5,8,14 TRIAZATETRACICLO [10.3.1.024 0.4.9] HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
UY28374A1 (en) THERAPEUTIC AGENTS
AR034897A1 (en) N-MONOACILATED DERIVATIVES OF O-PHENYLENDIAMINS, THEIR HETEROCICLICAL ANALOGS OF SIX MEMBERS AND THEIR USE AS PHARMACEUTICAL AGENTS
ECSP066643A (en) PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS AS PDE 2 INHIBITORS
HUP0402270A2 (en) [1,2,4]triazolo[1,5-c]pyrimidin-5-yl-amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing them
UY29893A1 (en) PIRAZINE DERIVATIVES
UY28144A1 (en) THERAPEUTIC AGENTS
EA200700144A1 (en) PYRIDOPYRIMIDINE DERIVATIVES, THEIR RECEIVING, THEIR APPLICATION IN THERAPY
UY28377A1 (en) THERAPEUTIC AGENTS
AR028250A1 (en) IMIDAZO [1,5-A] -PIRIDO [3,2-E] -PIRAZINONAS, THE USE OF SUCH COMPOUNDS AND ITS SALTS FOR THE PREPARATION OF MEDICINES AND THE MEDICINES SO PREPARED
DOP2002000390A (en) SALT CITRATE 5.8 14-HIEZATETRACICLO [10.3.1.0 2.11. 0.4.9] HEXADECA-2 (11), 3,5,8,9, PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
ECSP088250A (en) DERIVATIVES OF PIRAZOL AS THERAPEUTIC AGENTS
DK1534707T5 (en) Substituted 2,4-dihydropyrrolo [3,4-b] quinolin-9-one derivatives useful as phosphodiesterase inhibitors
GT200500381A (en) DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT
AR032520A1 (en) COMPOUNDS

Legal Events

Date Code Title Description
FB Suspension of granting procedure